Inventor · disambiguated record
Hua Yu
Also filed as: YU HUA · YU HUA E
25 granted patents·20 pending applications·102 citations·filing 2001–2024
95Inventor score
Top patents by PatentIndex Score
45 records- 0192US11912995B2CTLA-4 aptamer conjugatesHOPE CITY·Filed 2021·Granted Feb 27, 2024·1 cites·17 claims
- 0292US11186840B2CTLA-4 aptamer conjugatesHOPE CITY·Filed 2020·Granted Nov 30, 2021·2 cites·14 claims
- 0391US7638122B2Stat3 antagonists and their use as vaccines against cancerUNIV SOUTH FLORIDA·Filed 2003·Granted Dec 29, 2009·41 cites·12 claims
- 0489US10711272B2CTLA-4 aptamer siRNA speciesHOPE CITY·Filed 2015·Granted Jul 14, 2020·3 cites·16 claims
- 0588US10967070B2Cell penetrating conjugates and methods of use thereofHOPE CITY·Filed 2016·Granted Apr 6, 2021·3 cites·8 claims
- 0688US9688982B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2013·Granted Jun 27, 2017·7 cites·4 claims
- 0787US11208654B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2019·Granted Dec 28, 2021·1 cites·16 claims
- 0887US8748405B2Methods and compositions for the treatment of cancer or other diseasesYU HUA·Filed 2011·Granted Jun 10, 2014·7 cites·3 claims
- 0987US7763585B2Methods for inhibiting tumor cell proliferationUNIV SOUTH FLORIDA·Filed 2007·Granted Jul 27, 2010·7 cites·10 claims
- 1087US7238372B2Methods for inhibiting tumor cell proliferationUNIV SOUTH FLORIDA·Filed 2004·Granted Jul 3, 2007·20 cites·4 claims
- 1186US10253318B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2017·Granted Apr 9, 2019·3 cites·14 claims
- 1284US9200280B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·4 cites·3 claims
- 1383US2024309379A1Ctla-4 aptamer conjugatesHOPE CITY·Filed 2024·Application pending·0 cites
- 1482US10987428B2Phosphorothioate-conjugated miRNAs and methods of using the sameHOPE CITY·Filed 2019·Granted Apr 27, 2021·1 cites·16 claims
- 1580US7951374B2Methods for inhibiting STAT3 signaling in immune cellsUNIV SOUTH FLORIDA·Filed 2005·Granted May 31, 2011·1 cites·14 claims
- 1679US2023193258A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2021·Application pending·0 cites
- 1774US9200279B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·1 cites·4 claims
- 1872US2023250196A1Cell penetrating protein-antibody conjugates and methods of useHOPE CITY·Filed 2023·Application pending·0 cites
- 1968US11857633B2Phosphorothioate-conjugated miRNAs and methods of using the sameHOPE CITY·Filed 2021·Granted Jan 2, 2024·0 cites·20 claims
- 2065US2025312414A1Protein inhibitors of clostridium difficile toxin bTEXAS A & M UNIV SYS·Filed 2024·Application pending·0 cites
- 2165US2009227489A1STAT3 Agonists and Antagonists and Therapeutic Uses ThereofUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 2263US2024271082A1Genetically-modified saccharomyces yeast strains as preventative and therapeutic agentsFZATA INC·Filed 2022·Application pending·0 cites
- 2361US2010297061A1Stat3 antagonists and their uses as vaccines against cancerUNIV SOUTH FLORIDA·Filed 2009·Application pending·0 cites
- 2459US2008214436A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2007·Application pending·0 cites
- 2558US2007072822A1STAT3 agonists and antagonists and therapeutic uses thereofJOHNS HOPKINS UNIVERSITY A MAR·Filed 2006·Application pending·0 cites
- 2658US2024110176A1Phosphorothioate nucleic acid conjugates including dna editing enzymesHOPE CITY·Filed 2021·Application pending·0 cites
- 2756US11661463B2Cell penetrating protein-antibody conjugates and methods of useHOPE CITY·Filed 2016·Granted May 30, 2023·0 cites·14 claims
- 2855US12161691B2Protein inhibitors of clostridium difficile toxin bTEXAS A & M UNIV SYS·Filed 2020·Granted Dec 10, 2024·0 cites·13 claims
- 2955US8598230B2Methods for inhibiting tumor cell proliferationTURKSON JAMES·Filed 2010·Granted Dec 3, 2013·0 cites·23 claims
- 3055US2004052762A1Stat3 agonists and antagonists and therapeutic uses thereofFiled 2001·Application pending·0 cites
- 3153US11541121B2Phosphorothioate-conjugated peptides and methods of using the sameHOPE CITY·Filed 2018·Granted Jan 3, 2023·0 cites·19 claims
- 3252US9345682B2Inhibition of STAT3 signal transduction for human cancer therapyJOVE RICHARD·Filed 2006·Granted May 24, 2016·0 cites·6 claims
- 3352US2010247427A1Methods of inhibiting cell growth and methods of enhancing radiation responsesUNIV SOUTH FLORIDA·Filed 2006·Application pending·0 cites
- 3452US2024091364A1Cancer combination treatments using anti-stat3 nucleic acid conjugatesHOPE CITY·Filed 2020·Application pending·0 cites
- 3552US2015050288A1Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3UNIV JOHNS HOPKINS·Filed 2014·Application pending·0 cites
- 3650US12077575B2Humanized tetra-specific octavalent antibody against clostridium difficile toxin A and BFENG HANPING·Filed 2020·Granted Sep 3, 2024·0 cites·19 claims
- 3750US11607457B2Anti-cancer phosphorothioate-coupled peptide conjugates and methods of using the sameHOPE CITY·Filed 2018·Granted Mar 21, 2023·0 cites·11 claims
- 3849US2011195509A1Treatment of th17-mediated autoimmune disease via inhibition of stat 3PARDOLL DREW·Filed 2008·Application pending·0 cites
- 3946US11730789B2Cell penetrating antibodiesHOPE CITY·Filed 2016·Granted Aug 22, 2023·0 cites·13 claims
- 4044US2002022017A1Regulation of systemic immune responses utilizing soluble CD40Filed 2001·Application pending·0 cites
- 4143US2006030536A1Combination therapies for cancer and proliferative angiopathiesUNIV SOUTH FLORIDA·Filed 2005·Application pending·0 cites
- 4238US9045750B2Humanized lewis-Y specific antibody-based delivery of dicer substrate siRNA (D-siRNA) against STAT3MA YUELONG·Filed 2012·Granted Jun 2, 2015·0 cites·11 claims
- 4338US2018243436A1Therapeutic cell internalizing conjugatesHOPE CITY·Filed 2016·Application pending·0 cites
- 4436US2019111001A1Microparticulate system for colonic drug deliveryFENG HANPING·Filed 2017·Application pending·0 cites
- 4536US2011071210A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hua Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →